Please use this identifier to cite or link to this item:
|Title:||On international cost-sharing of pharmaceutical R&D|
|Keywords:||Ramsey pricing, coinsurance.|
|Abstract:||Ramsey pricing has been proposed in the pharmaceutical industry as a principle to price discriminate among markets while allowing to recover the (fixed) R&D cost. However, such analyses neglect the presence of insurance or the fund raising costs for most of drug reimbursement. By incorporating these new elements, we aim at providing some building blocks towards an economic theory incorporating Ramsey pricing and insurance coverage. We show how coinsurance affects the optimal prices to pay for the R&D investment. We also show that under certain conditions, there is no strategic incentive by governments to set coinsurance rates in order to shift the financial burden of R&D. This will have important implications to the application of Ramsey pricing principles to pharmaceutical products across countries.|
|Appears in Collections:||NSBE: Nova SBE - Artigos em revista internacional com arbitragem científica|
Files in This Item:
|RamseyPharmaceuticalsv11.pdf||154,06 kB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.